• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Localized Red Mass on a Toddler's Eyelid

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 7 No 3
Volume 7
Issue 3

This 20-month-old child has had a localized red mass on the right eyelid that had been present for a few weeks.

THE CASE: This 20-month-old child has had a localized red mass on the right eyelid that had been present for a few weeks.

Answer and discussion on next page

 

 

Chalazion is the correct answer.

DISCUSSION: The mass is a chalazion-a chronic lipogranulomatous inflammation that arises from obstruction of the sebaceous glands of the eyelid. This swelling, caused by stasis of oily gland secretions, can become superinfected with Staphylococcus aureus.1

A localized lid swelling may also be the result of an acute infection of a lid follicle or meibomian gland (a hordeolum) or an insect bite. Clinically, it can be difficult to distinguish a chalazion from a hordeolum. The diagnosis is based on the symptoms and findings on gross inspection of the eyelid and eye. On rare occasions, a recurrent eyelid lesion can be a malignancy-such as a sebaceous carcinoma.

Frequent warm compresses encourage spontaneous drainage. Local superinfection may require topical or (rarely) oral antibiotics. Infrequently, incision and drainage and intralesional corticosteroid injection by an ophthalmologist may be required.1

Online Poll

|

Online Survey

References:

REFERENCES:

  • 1. Bradford CA. The red eye. In: Bradford CA, ed. Basic Ophthalmology for Medical Students and Primary Care Residents. 7th ed. San Francisco: American Academy of Ophthalmology; 1999:70-71.
Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.